CoolSculpting

What CoolSculpting does

CoolSculpting is a medical-device brand operating in non-invasive aesthetic body contouring. Its core technology is proprietary cryolipolysis — controlled cooling that crystallizes and ruptures subcutaneous fat cells while preserving surrounding tissue, with built-in temperature sensors that automatically halt the system if skin temperature drifts out of safe range. The portfolio centers on the CoolSculpting and CoolSculpting Elite systems (FDA-cleared for 9 body areas: abdomen, flanks, submental/submandibular, thighs, upper arms, back fat, bra fat, banana roll), the complementary CoolTone magnetic muscle stimulation device, and the Allē patient loyalty and payment platform.

Revenue is generated transactionally: each treatment is priced per-area via consultation, patients typically require at least 2 sessions per area, and pricing is opaque / quote-based. Demand is driven direct-to-consumer through coolsculpting.com and the Allē app (education, before-and-after galleries, testimonial content, loyalty rewards), while delivery is fulfilled exclusively through a certified provider network of plastic surgeons, dermatologists, and medical spas surfaced via the Allē Directory. The Allē platform also integrates Cherry (0% APR-eligible installment financing) and cross-portfolio point earning with sibling Allergan/Aesthetics brands (JUVÉDERM fillers, SkinMedica skincare).

The brand originated with Allergan, was acquired by AbbVie in 2020, and operates today as a brand within AbbVie's Allergan Aesthetics portfolio rather than as an independent company; revenue, headcount, and financial performance are not disclosed at the CoolSculpting brand level.

Name

CoolSculpting

Legal name

CoolSculpting (brand owned by AbbVie)

Website

https://coolsculpting.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

CoolSculpting is an FDA-cleared, non-invasive body contouring brand that uses proprietary cryolipolysis (fat-freezing) technology to permanently eliminate treated fat cells in 9 body areas. It serves adult consumers seeking stubborn-fat reduction and is delivered through a certified provider network coordinated via the Allē loyalty and payments platform, under AbbVie ownership.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hot/Cold Therapy Services (Cryotherapy/Ice Baths) (HSALAFAH)

akta.pro secondary industry

Cryotherapy Services (HSADAKAE)

Keywords

• Non-invasive fat reduction
• Cryolipolysis treatments
• Body contouring devices
• Medical aesthetic systems
• Fat freezing technology

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Technology or R&D, Supply Chain, Personnel, Operations

Revenue model

1. Treatment Procedures: Revenue generated from CoolSculpting and CoolSculpting Elite cryolipolysis treatment sessions. Pricing varies based on treatment areas, number of sessions, and individual patient goals. Patients typically require at least 2 treatment sessions for desired results.
2. Allē Loyalty Program: Points-based loyalty program where patients earn points on eligible treatments and redeem for savings on future procedures. 100 points equals $10 off eligible treatments and products.
3. Payment Plans: Partnership with Cherry to offer installment payment plans allowing patients to pay over time. APR starts as low as 0% for eligible patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

CoolSculpting develops and markets FDA-cleared cryolipolysis (fat-freezing) treatment systems and related medical aesthetic devices that are administered through certified healthcare providers to permanently eliminate stubborn fat in 9 body areas without surgery. Its portfolio includes CoolSculpting® and CoolSculpting® Elite fat-reduction systems and the CoolTone® magnetic muscle stimulation device, supported by the Allē consumer loyalty and payment platform. Revenue is generated through device and treatment-related sales delivered via a global certified provider network.

Product overview

CoolSculpting offers a portfolio of body contouring products centered on cryolipolysis technology. The core product line includes CoolSculpting® (the original FDA-cleared fat-freezing treatment) and CoolSculpting® Elite (the advanced version with improved applicators), both using controlled cooling to permanently eliminate treated fat cells. Complementary to these is CoolTone®, an FDA-cleared magnetic muscle stimulation device for toning and firming muscles. The company also operates Allē, a proprietary loyalty and payment program that integrates with third-party payment provider Cherry for financing options. The portfolio targets 9 body areas for fat reduction and supports muscle toning for abdomen, buttocks, and thighs.

Differentiator

Problem solved

Functional benefit

Brands

• CoolTone: FDA-cleared muscle toning device that strengthens, tones, and firms the abdomen, buttocks, and thigh muscles using magnetic muscle stimulation.

Products and services

• CoolSculpting® FDA-cleared cryolipolysis (fat-freezing) treatment that permanently eliminates up to 20–25% of treated fat cells in 9 body areas (submental, submandibular, thigh, abdomen, flank, bra fat, back fat, banana roll, upper arm) without surgery or downtime. Delivered to adult patients (18+) by certified healthcare providers listed in the Allē Directory.
• CoolSculpting® Elite Advanced FDA-cleared version of the CoolSculpting system with improved applicator cup design for better tissue draw and more comprehensive treatment coverage of visible fat bulges in the same 9 FDA-cleared body areas. Delivered to patients by certified providers.
• CoolTone® FDA-cleared magnetic muscle stimulation device that strengthens, tones, and firms abdomen, buttocks, and thigh muscles using involuntary muscle contractions, complementing CoolSculpting fat reduction as a body contouring offering.
• Allē CoolSculpting's proprietary points-based loyalty and patient engagement platform (with iOS and Android apps) that lets patients earn points on eligible CoolSculpting treatments, JUVÉDERM fillers, and SkinMedica products, redeem points for savings (100 points = $10 off), discover seasonal offers, and access Cherry-powered installment payment plans.

Quantifiable outcome

• Up to 20-25% of treated fat permanently eliminated per treatment area
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• CherrycoreGTM or Marketing PartnerCherry provides payment plan infrastructure enabling CoolSculpting patients to pay for treatments over time in flexible monthly installments. Offers APR starting at 0% with no hard credit checks and no hidden fees. Integrated into the Allē platform for seamless patient financing.
• JUVÉDERM Collection of FillerscoreGTM or Marketing PartnerJUVÉDERM injectable gel fillers are featured in the Allē loyalty program as eligible products for earning points. This cross-portfolio partnership allows patients to earn and redeem points across multiple aesthetic treatments.
• SkinMedicacoreGTM or Marketing PartnerSkinMedica skincare products are part of the Allē loyalty program, allowing patients to earn points on purchases and redeem for savings across both CoolSculpting treatments and skincare products.
• Allē Provider NetworkcoreChannel Partner/ Reseller/ DistributorNetwork of certified healthcare providers (plastic surgeons, dermatologists, medical spas) who administer CoolSculpting treatments. Providers are listed in the Allē Directory and participate in the loyalty program, enabling patients to find specialists and earn points on treatments.
• BodifyminorOthersMedical aesthetics practice credited for patient photography in the before-and-after gallery for banana roll treatment area. Operated by Steven Sorr, NMD.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BTL Industries: Private medical-aesthetic device company behind Emsculpt NEO and Vanquish, which compete head-to-head with CoolSculpting/CoolTone for non-invasive fat reduction and muscle-toning consults in the same provider channel.
• Sciton: Private aesthetics/laser manufacturer whose body-contouring platforms compete with CoolSculpting for the same energy-based body shaping indication in dermatology and plastic-surgery practices.
• InMode: Public aesthetics device maker whose BodyTite, Evolve, and EvolveX platforms overlap directly with CoolSculpting and CoolTone for body contouring and muscle toning in clinics and med spas.
• Cutera: Public aesthetics device company selling truSculpt iD and truSculpt flex, which compete with CoolSculpting Elite on non-invasive body contouring through the same dermatologist and med-spa accounts.
• Cynosure (Hologic): Aesthetics/laser subsidiary of Hologic that markets SculpSure, a non-invasive laser lipolysis device positioned as a direct alternative to CoolSculpting in plastic-surgery and med-spa offices.
• Solta Medical (Bausch Health): Bausch Health subsidiary that markets Liposonix and Thermage, both non-invasive body-contouring/energy-based devices sold into the same physician and med-spa channel as CoolSculpting.

Others

• SkinCeuticals (L'Oréal Dermatological Beauty): Physician-dispensed skincare brand adjacent to the same aesthetics patient and provider ecosystem — competing for post-procedure skincare wallet alongside CoolSculpting's SkinMedica brand.

Broad incumbents

• Galderma: Major aesthetics and dermatology player (Restylane, Sculptra, skin-care lines) that overlaps with CoolSculpting's Allergan Aesthetics counterpart and competes for the same elective-aesthetic patient relationship, though it does not sell a cryolipolysis device.
• Merz Aesthetics: Incumbent aesthetics portfolio (Ultherapy, Radiesse, Belotero) that competes for the same elective-aesthetics patient wallet and the same physician channels, even though it does not directly compete in cryolipolysis.

Emerging players

• Evolus: Pure-play aesthetics challenger behind Jeuveau (botulinum toxin), operating in overlapping physician accounts and elective-aesthetic patient flow that CoolSculpting providers also serve.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/coolsculpting
• Xx.com/coolsculpting

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CoolSculpting